title: Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.
abstract: Despite its importance in shaping adaptive immune responses, viral clearance, and immune-based inflammation, tissue-specific innate immunity remains poorly characterized for hepatitis C virus (HCV) infection due to the lack of access to acutely infected tissues. In this study, we evaluated the impact of natural killer (NK) cells and myeloid (mDCs) and plasmacytoid (pDCs) dendritic cells on control of virus replication and virus-induced pathology caused by another, more rapidly resolving hepacivirus, GB virus B (GBV-B), in infections of common marmosets. High plasma and liver viral loads and robust hepatitis characterized acute GBV-B infection, and while viremia was generally cleared by 2 to 3 months postinfection, hepatitis and liver fibrosis persisted after clearance. Coinciding with peak viral loads and liver pathology, the levels of NK cells, mDCs, and pDCs in the liver increased up to 3-fold. Although no obvious numerical changes in peripheral innate cells occurred, circulating NK cells exhibited increased perforin and Ki67 expression levels and increased surface expression of CXCR3. These data suggested that increased NK cell arming and proliferation as well as tissue trafficking may be associated with influx into the liver during acute infection. Indeed, NK cell frequencies in the liver positively correlated with plasma (R = 0.698; P = 0.015) and liver (R = 0.567; P = 0.057) viral loads. Finally, soluble factors associated with NK cells and DCs, including gamma interferon (IFN-γ) and RANTES, were increased in acute infection and also were associated with viral loads and hepatitis. Collectively, the findings showed that mobilization of local and circulating innate immune responses was linked to acute virus-induced hepatitis, and potentially to resolution of GBV-B infection, and our results may provide insight into similar mechanisms in HCV infection.
  
  
  
  Hepatitis C virus (HCV) infection has created a global health crisis, and despite new effective antivirals, it is still a leading cause of liver disease and death worldwide. Recent evidence suggests that innate immunity may be a potential therapeutic target for HCV, but it may also be a correlate of increased disease. Due to a lack of access to human tissues with acute HCV infection, in this study we evaluated the role of innate immunity in resolving infection with a hepacivirus, GBV-B, in common marmosets. Collectively, our data suggest that NK cell and DC mobilization in acute hepacivirus infection can dampen virus replication but also regulate acute and chronic liver damage. How these two opposing effects on the host may be modulated in future therapeutic and vaccine approaches warrants further study.
authors.affiliation: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
authors.forename: Cordelia
authors.initials: C
authors.lastname: Manickam
authors.affiliation: Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
authors.forename: Premeela
authors.initials: P
authors.lastname: Rajakumar
authors.affiliation: New England Primate Research Center, Harvard Medical School, Southborough Campus, Southborough, Massachusetts, USA.
authors.forename: Lynn
authors.initials: L
authors.lastname: Wachtman
authors.affiliation: New England Primate Research Center, Harvard Medical School, Southborough Campus, Southborough, Massachusetts, USA.
authors.forename: Joshua A
authors.initials: JA
authors.lastname: Kramer
authors.affiliation: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
authors.forename: Amanda J
authors.initials: AJ
authors.lastname: Martinot
authors.affiliation: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
authors.forename: Valerie
authors.initials: V
authors.lastname: Varner
authors.affiliation: Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, Texas, USA.
authors.forename: Luis D
authors.initials: LD
authors.lastname: Giavedoni
authors.affiliation: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA New England Primate Research Center, Harvard Medical School, Southborough Campus, Southborough, Massachusetts, USA rreeves@bidmc.harvard.edu.
authors.forename: R Keith
authors.initials: RK
authors.lastname: Reeves
mesh_terms: D000818:Animals; D002144:Callithrix; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology*; D029406:GB virus B / Q000276:immunology* / Q000472:pathogenicity; D006524:Hepatitis, Viral, Animal / Q000276:immunology* / Q000473:pathology*; D007113:Immunity, Innate; D007155:Immunologic Factors / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology*; D008099:Liver / Q000473:pathology / Q000821:virology; D019562:Viral Load
chemical_list: D016207:Cytokines; D007155:Immunologic Factors